Lymphedema in ovarian cancer survivors: Assessing diagnostic methods and the effects of physical activity
Authors:
- 13 February 2018
- Vol. 124 (9) , 1929-1937
Abstract
BACKGROUND: Lymphedema is a poorly understood side effect of gynecologic cancer treatment. This study was designed to determine the prevalence of lower limb lymphedema (LLL) in a sample of ovarian cancer survivors via 3 different diagnostic methods and to assess the effect of a randomized exercise intervention.METHODS: Physically inactive ovarian cancer survivors (n = 95) were enrolled in a 6‐month randomized trial of exercise (primarily brisk walking) versus attention control. LLL was measured at baseline and 6‐month visits via a self‐report questionnaire, optoelectronic perometry, and an evaluation by a certified lymphedema specialist.RESULTS: LLL prevalence ranged from 21% to 38% according to the diagnostic method, and there was substantial agreement between the self‐report questionnaire and the lymphedema specialist evaluation (κ = 0.61). There was no agreement between the evaluation with optoelectronic perometry and the specialist evaluation. With LLL defined by any method, the baseline prevalence was 38% in both groups. At 6 months, both groups experienced a decreased LLL prevalence: 28% in the exercise group and 35% in the control group. There was no difference in the change in lymphedema prevalence between the 2 groups (P = .64). Body mass index was a significant predictor of LLL.CONCLUSIONS: With a potential prevalence of LLL as high as 40%, further evaluation of diagnostic methods is required to better characterize this side effect of ovarian cancer treatment. No adverse effect of exercise on LLL was found. Further research is strongly needed to evaluate predictors of LLL and the effects of exercise on LLL in order to develop effective physical activity recommendations for women with ovarian cancer. Cancer 2018;124:1929‐37. © 2018 American Cancer Society.Keywords
Funding Information
- National Center for Advancing Translational Sciences
- National Institute on Aging (P30AG021334)
- National Cancer Institute (R21AG053198)
This publication has 24 references indexed in Scilit:
- Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health StudyBreast Cancer Research and Treatment, 2011
- Reliability and Concurrent Validity of the Perometer for Measuring Hand Volume in Women With and Without LymphedemaLymphatic Research and Biology, 2011
- Body mass index and breast cancer treatment-related lymphedemaSupportive Care in Cancer, 2011
- Lymphedema and Quality of Life in Breast Cancer Survivors: The Iowa Women's Health StudyJournal of Clinical Oncology, 2008
- Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective MeasurementsJournal of Clinical Oncology, 2008
- A Primer in Longitudinal Data AnalysisCirculation, 2008
- Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White womenBreast Cancer Research and Treatment, 2008
- Lymphedema in Gynecologic Cancer SurvivorsCancer Nursing, 2007
- Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancerSupportive Care in Cancer, 2004
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI: Journal of the National Cancer Institute, 2000